Претраживање
Приказ резултата 1-2 од 2
Non-oncological drug-induced blood disorders: a cost of illness study using the microcosting Methodology - study plan [protocol]
(2022)
Drug-induced disorder „can result from unanticipated or anticipated drug effects“ (1).
The prevalence of hematological adverse drug reactions (ADR) in chemotherapeutics is
expected to be high; for non-chemotherapeutics, ...
Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation
(2024)
The low aqueous and oil solubility of the novelpyrazoloquinolinone ligand (CW-02-79) with significantbinding affinity for sigma-2 receptors in the brain hindersthe development of conventional parenteral formulationsand ...